Search Results 281-290 of 16004 for pharmacogenetics

  1. Genetic Evidence That New Therapies Targeting Parkinson's Disease May Cause Harm - Mayo Clinic News Network

    Mayo Clinic neurology experts are presenting research findings on Parkinson's disease, Alzheimer's disease, sleep disorders, concussions, multiple sclerosis and ...

  2. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Learn how Dr. Ling's Phospholipid Signaling in Embryonic Development and Human Diseases Lab at Mayo Clinic studies the roles of phosphoinositide species and ...

  3. Atrial Fibrillation - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    Polygenic risk · Heart palpitations. · Irregular heart rhythm or rate. · A feeling of skipped beats or irregular beats that last for a few seconds or more.

  4. Science Saturday: Mayo Clinic doctor visits of the future could be powered by 'omics' research

    Omics is an emerging multidisciplinary field of biological sciences, in which researchers use a toolkit of scientific precision methods.

  5. Clinical Core

    The Clinical Core of the Center for Cell Signaling in Gastroenterology supports faculty research by facilitating access to human biospecimens through two ...

  6. Efbemalenograstim alfa-vuxw (subcutaneous route) - Mayo Clinic

    Efbemalenograstim alfa-vuxw injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form ...

  7. Fibrinogen/aprotinin and thrombin/calcium chloride (topical application route, route not applicable) - Mayo Clinic

    It is also used to help skin tissues stick together during skin graft or cosmetic surgery (eg, burn treatment or facelift procedures). This medicine is a fibrin ...

  8. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...

  9. Antiviral Drugs and COVID-19 - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

    Dr. Caulfield's Drug Discovery, Design and Optimization for Novel Therapeutics Lab at Mayo Clinic studies how to prevent viruses from binding, entering and ...

  10. Palopegteriparatide (subcutaneous route) - Mayo Clinic

    Palopegteriparatide injection is used to treat hypoparathyroidism (low parathyroid hormone). This medicine is a synthetic form of the natural human parathyroid ...